Back to
Nuveen Asset Management, LLC
AXSM
23 quarters
Position history for
Nuveen Asset Management, LLC's holdings in Axsome Therapeutics, Inc.
As of its last 13F, for Q4 2024, Nuveen Asset Management held 221,202 shares of AXSM (Axsome Therapeutics), worth $18.7M. It increased the position by 119,780 shares (+118.1%) from Q3 2024. Nuveen Asset Management held AXSM from Q2 2019 to Q4 2024, across 23 quarterly 13F filings.
Current Value
$18.7M
Current Shares
221,202
Total Value Change
+$16.2M
Total Shares Change
+123,480
Quarter-by-Quarter History
Other major holders of AXSM: Vanguard Group Inc., BlackRock, Inc.